Morning Report | Crude slides on Iran risk unwind; AI semis rip
$USO Crude dumps, Hormuz escorts pause · $AMD Data-center signals spark breakout · $MU AI memory bid stays hot · $JETS Fuel-cost shock hits airlines · $ITB New-home sales up, prices down
Market Pulse
U.S.-Iran War
5 events
Diplomacy headlines swing U.S.-Iran war risk premium as Hormuz escorts pause and mine threats persist, sending crude sharply lower into the open.
Last 24 hours
U.S. Central Command launched “Project Freedom” to route commercial ships through a U.S.-cleared Hormuz lane after reported Iranian mine-laying, using MQ-9 and geospatial support for mine-hunting.
Officials said roughly 1,550 commercial vessels are stuck in the Persian Gulf; only two U.S. commercial ships have left since Project Freedom began, with hundreds reportedly lining up to transit.
Axios reported the U.S. and Iran are close to a one-page 14-point memorandum to end the war and set a nuclear-talks framework, with the White House expecting an Iranian response within about 48 hours.
President Trump said Project Freedom will be paused briefly to see if an agreement can be finalized, while the U.S. blockade of Iranian ports remains in effect; analysts cited escorted capacity far below pre-war traffic.
The Pentagon said the ceasefire still holds and Iran’s actions are “below the threshold,” citing post-ceasefire incidents including nine firings at commercial vessels, two seizures, and more than 10 attacks on U.S. forces.
Market reaction
Oil sold off on de-escalation headlines: Brent was down about 9.2% to roughly $99.79/bbl around 6:58 a.m. ET (reported as low as below $98) and WTI fell about 10.9% to roughly $91.10 (reported near $90). In the prior session, Brent settled near $109.87 (-~4%) and WTI near $102.27 (-~4%).
Our view
A near-term compression of the crude risk premium as talks progress, but with elevated volatility because Hormuz transit normalization looks operationally constrained. The key monitor is Iran’s expected response within ~48 hours and whether the 30-day negotiation framework holds without renewed mine or ship-attack disruptions.
What could change our view
Iran rejects or delays the memorandum, restarting escalation and widening the oil risk premium.
New mine discoveries or attacks materially reduce safe Hormuz throughput despite escorts.
Tickers: $USO, $CL=F, $BZ=F
AI
5 events
AI semis extend risk-on tape as AMD, Micron and Super Micro surge on upbeat data-center signals while regulators step up frontier-model testing.
Last 24 hours
AMD posted Q1 revenue of $10.27B (+38% y/y) and net income of $1.38B, with Data Center revenue $5.8B (+57% y/y) and Q2 revenue guided to about $11.2B versus $10.52B consensus.
Micron shares rose about 11% on May 5, lifting its market cap above $700B as it began shipping its largest commercially available SSD amid a global memory shortage and customers reportedly receiving only 50%–two-thirds of requirements.
Super Micro gained about 18% in extended trading after guiding fiscal Q4 revenue of $11.0B–$12.5B and adjusted EPS of $0.65–$0.79 despite a fiscal Q3 revenue miss; management cited customer power/network readiness delays and component shortages.
Commerce/NIST’s CAISI signed agreements with Google DeepMind, Microsoft and xAI for pre-deployment evaluations of frontier models, including potential testing with safeguards reduced and participation across agencies via the interagency TRAINS Taskforce in classified settings.
Samsung shares jumped more than 15% on May 6, pushing market cap above $1T after record Q1 results; the rally was tied to tightening DRAM/NAND/HBM supply and cited HBM4 mass production and deliveries amid multi-year capacity lead times.
Market reaction
AI-linked hardware momentum is translating directly into price action: AMD was up ~20% premarket, Micron rose ~11% and Super Micro gained ~18% after hours, while Samsung surged >15% overseas—setting a positive read-through for SMH/SOXX.
Our view
Continued near-term leadership from AI compute and memory beneficiaries as strong guidance and tight supply keep the tape bid. The next check is whether deployment bottlenecks (power/network readiness) and component constraints ease enough to convert demand into recognized revenue while policy testing frameworks remain voluntary rather than gating.
What could change our view
Power and networking constraints materially extend deployment timelines and revenue recognition.
Pre-release model evaluations evolve into mandatory gating that chills AI capex.
Tickers: $AMD, $MU, $SMCI, $QQQ
Airlines
3 events
Airlines face a fuel-cost shock as Spirit winds down while Frontier expects near-term pricing power from overnight capacity removal.
Last 24 hours
Lufthansa guided to about €1.7B in incremental 2026 fuel costs tied to Middle East conditions, with roughly 80% of jet fuel hedged and additional short-haul flight cuts to save fuel.
Spirit filed a roughly $217M wind-down budget through Feb 2028 and halted operations around 3 a.m. ET Saturday, citing about $100M in incremental fuel costs since March 1 and a failed ~$500M loan plan.
Frontier expects a 3%–5% RASM lift and guided Q2 unit revenue up more than 20% on reduced overlap competition after Spirit’s exit, while warning competitors are already signaling route additions including JetBlue at Fort Lauderdale.
Market reaction
Frontier shares rose more than 6% after its Q1 results, reflecting positioning for near-term unit revenue gains as Spirit capacity disappears.
Our view
The group stays bifurcated—fuel-driven cost pressure is the dominant macro headwind, but Spirit’s removal creates a temporary revenue tailwind for overlapping carriers such as Frontier. Watch jet-fuel supply/price stability and the pace of capacity backfill, including additions at Fort Lauderdale, to gauge durability.
What could change our view
Jet fuel prices normalize quickly, easing cost pressure and narrowing relative winners.
Rapid capacity redeployment on ex-Spirit routes erodes expected RASM uplift.
Tickers: $JETS, $SAVE, $ULCC
Macro & Policy Digest
Credit-score policy shifts at the GSEs and stronger March new-home sales alongside lower prices frame a volume-versus-margins debate for builders.
Last 24 hours
FHFA will allow lenders to use VantageScore 4.0 for loans sold to Fannie/Freddie, starting with 21 large lenders; Freddie Mac has already purchased about $10 million of such loans, with FICO 10T expected in coming months.
March new single-family home sales rose to 682,000 SAAR (+7.4% m/m, +3.3% y/y) versus a 652,000 forecast, while the median new-home price fell to $387,400 (-5.3% m/m, -6.2% y/y) as March average 30-year rates were cited at 6.18%.
Our view
Near-term homebuilder fundamentals stay mixed, with better new-build volumes offset by continued incentive-driven price pressure that caps margin upside. Key monitor is whether expanded credit-score options translate into looser effective underwriting and sustained absorption without further pricing concessions.
What could change our view
Credit-score rollout materially expands qualified buyers faster than expected.
Deeper discounting needed to hold sales, driving sharper margin compression.
Tickers: $ITB
SEC floats opt-in semiannual reporting while FDA clears first fruit-flavored e-cigarette pods, setting new disclosure and nicotine-product rulemaking watchpoints.
Last 24 hours
The SEC proposed an optional semiannual reporting path allowing eligible issuers to file a new Form 10-S instead of quarterly 10-Qs, with election at fiscal-year start and a 60-day comment window.
The FDA authorized Glas Inc. mango and blueberry e-cigarette pods plus two menthol variants, requiring ID-based age verification and device access restrictions, and reserving the right to suspend or withdraw authorization.
Our view
Both actions stay narrow and procedural near term, with limited immediate index impact as companies and regulators test optional regimes and access-controls. Watch SEC comment process and any majority vote, plus FDA post-market monitoring that could suspend or withdraw the authorization.
What could change our view
SEC adopts rule quickly, shifting disclosure cadence and earnings information flow.
FDA withdraws authorization after post-market evidence of higher youth use.
Tickers: $SPY, $MO
U.S.-escorted Hormuz transit offers a test of limited commercial passage as war-driven shipping halt keeps energy and freight risk premia elevated.
Last 24 hours
Maersk said its U.S.-flagged Alliance Fairfax, stranded since Feb. 28, transited the Strait of Hormuz under U.S. military protection without incident; U.S. Central Command also reported two U.S.-flagged transits and destroyers operating nearby.
Our view
Escorted transits enable only limited, intermittent Hormuz passage, so crude-linked risk premia stay elevated until traffic normalizes beyond U.S.-flagged convoys. Watch for evidence of broader commercial routing and Maersk’s Q1 earnings commentary on demand, costs, and rerouting tied to Middle East disruptions.
What could change our view
Sustained multi-flag commercial transits reduce insurance and energy risk premia quickly.
New incidents in Hormuz halt escorted passage and spike disruption fears.
Tickers: $CL=F
Company Events
Crypto equities digest balance-sheet and cost-base resets as MSTR loosens bitcoin-sale taboo and Coinbase cuts staff ahead of Thursday earnings.
Last 24 hours
Strategy said it may sell bitcoin for USD or to retire debt when accretive to “bitcoin per share”, citing liquidity needs; it ended Q1 with 818,334 BTC and a $2.25B dollar reserve.
Coinbase will cut about 14% of headcount (~700 roles) and expects $50–$60M in restructuring charges, with the plan substantially complete in Q2, announced ahead of its scheduled Q1 earnings Thursday.
Market reaction
COIN shares were reported gaining after the cost-cut announcement.
Our view
Crypto-linked equities stay driven by balance-sheet and cost-discipline narratives, with COIN’s cuts supporting margin expectations while MSTR’s flexibility reduces near-term funding stress. Next key monitor is Thursday’s COIN earnings for evidence the resized expense base can offset revenue volatility, alongside any disclosed BTC-sale execution from MSTR.
What could change our view
COIN earnings reveal weaker profitability despite cuts and $50–$60M charges.
MSTR bitcoin sales signal broader liquidity strain or accelerate selling pressure.
Tickers: $MSTR, $COIN
CVS lifts 2026 guidance on stronger Aetna trends as Pfizer beats Q1 but holds 2026 targets amid Covid product normalization.
Last 24 hours
CVS reported Q1 revenue of $100.43B (+6.2% y/y) and adjusted EPS of $2.57, then raised 2026 EPS to $7.30–$7.50 and revenue to at least $405B, citing Aetna tailwinds.
Pfizer posted Q1 revenue of $14.45B (+5% y/y) and adjusted EPS of $0.75, reaffirming 2026 adjusted EPS of $2.80–$3.00 and revenue of $59.5B–$62.5B despite weaker Covid vaccine and Paxlovid sales.
Market reaction
CVS was up more than 4% in premarket trading after the Q1 beat and higher 2026 guidance.
Our view
Expect healthcare tape to stay earnings-driven, with investors rewarding visible margin and underwriting improvements (CVS/Aetna) while treating reaffirmations amid product normalization (PFE) as neutral. Next monitor is whether CVS sustains MBR discipline and whether Pfizer’s base-business growth continues to offset Covid-related declines within its 2026 framework.
What could change our view
CVS insurance trends reverse, pushing MBR higher and undermining raised 2026 targets.
Pfizer Covid-related sales undershoot further without sufficient base-business offsets.
Tickers: $CVS, $PFE
U.S. consumer bellwethers DIS and QSR beat expectations, highlighting resilient spend pockets while brand-level dispersion keeps the read-through selective.
Last 24 hours
Disney fiscal Q2 revenue rose 7% to $25.17B with experiences and streaming growth; it lifted its FY share repurchase target to at least $8B and guided to ~12% adjusted earnings growth.
Restaurant Brands Q1 revenue rose 7% to $2.26B with same-store sales up 3.2%; Burger King outperformed while Tim Hortons lagged expectations and Popeyes posted a sharper same-store sales decline.
Market reaction
Disney shares were up about 5% premarket (May 6) following the quarter and higher buyback target.
Our view
Maintain a modestly constructive stance on U.S. consumer exposure tied to experiences and value-led quick service, but expect uneven performance across subsectors and brands. Watch for follow-through in parks demand and sustained Burger King momentum to offset weaker pockets like Popeyes and softer domestic park visitation.
What could change our view
Parks demand softens further, undermining the durability of the Disney beat.
QSR brand dispersion worsens, with Popeyes weakness outweighing Burger King gains.
Tickers: $DIS, $QSR
Novo lifts 2026 guidance as U.S. Wegovy pill launch outperforms, refocusing GLP-1 debate on oral adoption and prescription momentum.
Last 24 hours
Novo raised 2026 currency-adjusted guidance to a 4%–12% decline in adjusted sales and operating profit, after Q1 included U.S. Wegovy pill sales of 2.26bn DKK vs 1.16bn estimate and ~1.3m prescriptions.
Market reaction
NVO shares rose about 7% in Copenhagen following the guidance lift and stronger-than-expected initial U.S. Wegovy pill sales.
Our view
The oral Wegovy launch improves Novo’s medium-term GLP-1 revenue visibility and supports relative strength versus peers as payer coverage develops. Watch prescription growth and the gap between reported and adjusted results, given the prior $4.2bn 340B provision reversal’s impact on comparability.
What could change our view
U.S. Wegovy pill prescriptions stall, undermining payer coverage and refill persistence assumptions.
Adjusted sales and profit deteriorate beyond the new 2026 guidance range.
Tickers: $NVO
Go deeper -
For intraday developments, follow our Midday posts.
For the close, the wrap, and next-day trade ideas, read Evening Insights.
For deeper work, Forward Valuation covers multi-week single-name setups (paid subscribers only).
Deep Dive is where we publish our full thematic research for paid subscribers.
Informational only; not investment advice. Sources deemed reliable.